Please assess the completion status of the following clinical trial:

Trial Title: A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, \>=18 years of age;~* kidney transplant \>=6 months and \<5 years prior to randomization;~* anemia;~* no ESA therapy during 3 months prior to randomization.~Exclusion Criteria:~* requirement for hemodialysis or peritoneal dialysis within 3 months prior to randomization;~* change in Hb concentration \>=1.5g/dL during screening period;~* transfusion of red blood cells during 3 months prior to randomization;~* poorly controlled hypertension;~* significant acute or chronic bleeding within 3 months prior to randomization.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).